TODDE, SERGIO CAMILLO
 Distribuzione geografica
Continente #
NA - Nord America 5.458
EU - Europa 2.673
AS - Asia 851
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 5
OC - Oceania 2
Totale 9.012
Nazione #
US - Stati Uniti d'America 5.357
IT - Italia 568
DE - Germania 514
SE - Svezia 463
CN - Cina 396
IE - Irlanda 301
UA - Ucraina 222
SG - Singapore 218
GB - Regno Unito 173
RU - Federazione Russa 150
HK - Hong Kong 121
CA - Canada 101
FI - Finlandia 64
AT - Austria 62
FR - Francia 37
DK - Danimarca 36
VN - Vietnam 33
IN - India 23
BE - Belgio 20
NL - Olanda 18
ID - Indonesia 16
TR - Turchia 12
BG - Bulgaria 10
CZ - Repubblica Ceca 10
JP - Giappone 10
PL - Polonia 9
IR - Iran 7
PE - Perù 6
EU - Europa 5
KR - Corea 5
RO - Romania 5
AR - Argentina 4
CO - Colombia 3
ES - Italia 3
PT - Portogallo 3
SA - Arabia Saudita 3
CL - Cile 2
MY - Malesia 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BR - Brasile 1
CH - Svizzera 1
EC - Ecuador 1
ET - Etiopia 1
JO - Giordania 1
LT - Lituania 1
ME - Montenegro 1
MU - Mauritius 1
PH - Filippine 1
SC - Seychelles 1
TW - Taiwan 1
Totale 9.012
Città #
Ann Arbor 1.568
Fairfield 433
Houston 372
Woodbridge 359
Wilmington 324
Chandler 321
Ashburn 284
Dublin 284
Jacksonville 245
Dearborn 194
Frankfurt am Main 189
Singapore 174
New York 171
Seattle 164
Cambridge 135
Milan 127
Hong Kong 116
Princeton 112
Nanjing 83
Altamura 59
Vienna 59
Shanghai 55
Lawrence 49
Lachine 39
Beijing 37
San Diego 34
Santa Clara 31
Boardman 29
Shenyang 25
Nürnberg 24
Hebei 23
Toronto 22
Guangzhou 21
Lissone 21
Brussels 20
Tianjin 20
Falls Church 19
Nanchang 19
Rome 19
Andover 18
Helsinki 18
Changsha 17
Dong Ket 17
Fremont 16
Jiaxing 16
Montréal 15
Jinan 14
London 13
Ottawa 13
Jakarta 12
Kunming 11
Ningbo 11
Brno 10
Edmonton 10
Los Angeles 10
Plovdiv 10
Bologna 9
Auburn Hills 8
Genoa 8
Huizen 8
Munich 8
Phoenix 8
Carate Brianza 7
Mountain View 7
Norwalk 7
Padova 7
Washington 7
Catania 6
Chicago 6
Detroit 6
Lima 6
Segrate 6
Taizhou 6
Turin 6
University Park 6
Biassono 5
Philadelphia 5
San Mateo 5
Tokyo 5
Zhengzhou 5
Amsterdam 4
Borgo Valsugana 4
Cardano al Campo 4
Costa Mesa 4
Hangyang 4
Kiev 4
Polska 4
Pune 4
Redmond 4
Tappahannock 4
Bari 3
Bogotá 3
Buffalo 3
Chengdu 3
Clearwater 3
Dallas 3
Emmen 3
Florence 3
Hefei 3
Ho Chi Minh City 3
Totale 6.738
Nome #
Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol 371
Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: A PET imaging and metabolomics-mass-spectrometry study 368
Study of the Tissue Distribution of TLQP-21 in Mice Using [18F]JMV5763, a Radiolabeled Analog Prepared via [18F]Aluminum Fluoride Chelation Chemistry 333
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study 303
11C-Labelling of N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide Derivatives and Evaluation as Potential Radioligands for PET imaging of Dopamine D3 Receptors 301
In vivo imaging of adenosine A2A receptors in rat and primate brain using [11C]SCH442416 285
A novel versatile precursor suitable for 18F-radiolabeling via “click chemistry” 270
11C-radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]Zofenoprilat 250
Improved synthesis and radiolabeling of [C-11]MP4A, a suitable ligand for the investigation of the cholinergic system using PET 202
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 200
Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation 191
VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells 185
Sperimentazione clinica con radiofarmaci 179
Cholinergic ligand [C-11]MP4A: Improved 4-acetoxypiperidine precursor synthesis via LC-APCI/MS characterisation and improved radioligand HPLC purification 176
EANM Guideline on the validation of analytical methods for radiopharmaceuticals 176
Radiosynthesis of [123I]βCIT, a selective ligand for the study of the dopaminergic and serotoninergic systems in human brain 175
[11C]RN5: A new agent for the in vivo imaging of myocardial α1-adrenoceptors 172
Preparation of [11C]radioligands with high specific radioactivity on a commercial PET tracer synthesizer 172
Development of a bicistronic vector for multimodality imaging of estrogen receptor activity in a breast cancer model: preliminary application 170
Synthesis and in vivo evaluation of 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D-4 receptors antagonist for PET 163
Quality Control in the Production of Radiopharmaceuticals 160
Asymmetric synthesis and preliminary evaluation of (R)- and (S)-[11C]bisoprolol, a putative beta1-selective adrenoceptor radioligand 158
Systemic and cerebral kinetics of 16α[18F]fluoro-17β-estradiol: A ligand for the in vivo assessment of estrogen receptor binding parameters 158
Sensitive GC-MS method for the determination of specific-activity of 16a[18F]Fluoro-estra-1,3,5(10)-triene-3,17b-diol 158
Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals 157
Produzione e verifiche di qualità dei radiofarmaci estemporanei per PET e terapia 156
European regulations for the introduction of novel radiopharmaceuticals in the clinical setting 154
Rsdiofarmaci marcati con fluoro-18 152
Synthesis and in vivo evaluation of [C-11]CGP62349, a new GABA(B) receptor antagonist 150
Automated production of copper radioisotopes and preparation of high specific activity [(64)Cu]Cu-ATSM for PET studies 150
Intake risk and dose evaluation methods for workers in radiochemistry labs of a medical cyclotron facility 144
Measurements and evaluation of the risks due to external radiation exposures and to intake of activated elements for operational staff engaged in the maintenance of medical cyclotrons 144
Automation of [C-11]acyl chloride syntheses using commercially available C-11-modules 143
EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD) 142
Synthesis and in vivo evaluation of [11C]ICI 118551 as a putative subtype selective β2-adrenergic radioligand 140
Synthesis and carbon-11 labeling of (R)- and (S)-Thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for Positron Emission Tomography 137
High yield synthesis of [11C]-acetone through selective quenching of methyl lithium 137
Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma 137
Measurement and control of the air contamination generated in a medical cyclotron facility for PET radiopharmaceuticals 134
PET in psychopharmacology 128
Synthesis and Biodistribution of (R,S)-[O-Methyl-11C]-1-[3-(5-Methoxy-1,2,3,4-Tetrahydro-1-Naphtalenyl)Propyl]-4-Phenylpiperazine (PNU-157760), A Putative Radioligand for 5-HT1A Receptors 128
Labeling and evaluation of N-[11C]methylated quinoline-2-carboxamides as potential radioligands for visualization of peripheral benzodiazepine receptors 127
Decommissioning procedures for an 11 MeV self-shielded medical cyclotron after 16 years of working time 125
Synthesis of [O-methyl-11c]fluvoxamine-a potential serotonin uptake site radioligand 118
Guidance on validation and qualification of processes and operations involving radiopharmaceuticals 114
Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A2A receptor system using positron emission tomography [2] 113
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach 113
A PET follow-up study of recovery after stroke in acute aphasics 93
PET imaging and single-cell RNA sequencing glioma microenvironment assessment after RT combined therapy 91
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification 88
Classificazione ambientale 87
Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals 84
Mild synthesis of [N-methyl-11C]-isovaleroyl-(L)-carnitine. The usefulness of a tritium approach. 77
Guidance on current good radiopharmacypractice for the small-scale preparation of radiopharmaceuticals using automated modules: a European perspective 71
From radiotracer to radiopharmaceutical: a philosophical approach 62
PET radiopharmacy and automation 59
Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals 53
Highlight selection of radiochemistry and radiopharmacy developments by editorial board 44
EANM guideline on quality risk management for radiopharmaceuticals 31
Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method 29
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 26
Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals 24
Highlight selection of radiochemistry and radiopharmacy developments by editorial board 23
Radiopharmaceutical need between the clinic and regulatory agencies: how philosophy could explain 'the road taken' 22
Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework 12
Totale 9.395
Categoria #
all - tutte 29.454
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.454


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.385 0 0 119 138 168 206 240 111 161 108 110 24
2020/20211.445 59 71 153 160 117 120 140 112 127 136 106 144
2021/20221.021 89 111 168 136 35 59 62 69 49 59 77 107
2022/20231.344 164 387 84 134 100 197 26 78 71 19 57 27
2023/20241.109 44 40 56 39 147 310 211 40 85 12 8 117
2024/2025454 137 251 66 0 0 0 0 0 0 0 0 0
Totale 9.395